[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Controversies in Neurology
November 2009

Generic Anticonvulsant Use in ChildrenDo We Have Evidence to Recommend Brand Formulations?

Author Affiliations

Author Affiliation:Division of Child Neurology, Ohio State University College of Medicine, Columbus.



Arch Neurol. 2009;66(11):1417-1418. doi:10.1001/archneurol.2009.233

Although it has been suggested that generic substitution of anticonvulsant medication may not result in health care cost savings,1one could argue that we need to look closer at how and when generic drugs are used and the current evidence available prior to making such conclusions. Because most anticonvulsant medications have or soon will have a generic formulation available, it is important to consider whether there is ample evidence to suggest that they are adequate. This article will provide arguments to suggest that generic formulations are a good thing.

First Page Preview View Large
First page PDF preview
First page PDF preview